In a filing, CME Group Inc revealed its Director SHEPARD WILLIAM R acquired Company’s shares for reported $69282.0 on Jun 25 ’25. In the deal valued at $270.53 per share,256 shares were bought. As a result of this transaction, SHEPARD WILLIAM R now holds 258,196 shares worth roughly $74.13 million.
Then, SHEPARD WILLIAM R bought 11 shares, generating $3,054 in total proceeds. Upon buying the shares at $270.53, the Director now owns 2,455 shares.
Before that, Carey Charles P sold 500 shares. CME Group Inc shares valued at $132,676 were divested by the Director at a price of $265.35 per share. As a result of the transaction, Carey Charles P now holds 4,900 shares, worth roughly $1.41 million.
UBS downgraded its CME Group Inc [CME] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who increased its forecast for the stock in early April from “an Equal-weight” to “an Overweight”. Raymond James also remained covering CME and has increased its forecast on March 10, 2025 with a “an Outperform” recommendation from previously “Mkt perform” rating. Citigroup revised its rating on January 06, 2025. It rated CME as “a Neutral” which previously was an “a Buy”.
Price Performance Review of CME
On Monday, CME Group Inc [NASDAQ:CME] saw its stock jump 2.26% to $287.1. Over the last five days, the stock has gained 4.74%. CME Group Inc shares have risen nearly 51.89% since the year began. Nevertheless, the stocks have risen 23.63% over the past one year.
How much short interest is there in CME Group Inc?
A steep rise in short interest was recorded in CME Group Inc stocks on 2025-07-15, dropping by -0.95 million shares to a total of 4.73 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 5.67 million shares. There was a decline of -20.0%, which implies that there is a negative sentiment for the stock.
